Major institutional stakeholders in InflaRx N.V. (IFRX) comprise a collection of dedicated healthcare-focused venture funds, domestic and international asset managers, and specialized biotechnology investment firms. While individual retail investors hold a notable segment of the float, institutional ownership includes professional investment advisors and alternative asset management groups that participate in secondary public offerings to fund ongoing clinical development trials and drug pipeline expansion.